- Home
- UA vs INVA Comparison
UA vs INVA Comparison
Compare UA & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UA | INVA |
|---|---|---|
| Founded | 1996 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 2005 | 2000 |
Fundamental Metrics
Financial Performance| Metric | UA | INVA |
|---|---|---|
| Price | $4.82 | $21.27 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $35.00 |
| AVG Volume (30 Days) | ★ 2.2M | 593.2K |
| Earning Date | 11-06-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 816.67 |
| EPS | N/A | ★ 1.25 |
| Revenue | ★ $4,966,370,000.00 | $217,217,000.00 |
| Revenue This Year | N/A | $9.72 |
| Revenue Next Year | $2.20 | $8.58 |
| P/E Ratio | ★ N/A | $17.04 |
| Revenue Growth | N/A | ★ 62.63 |
| 52 Week Low | $3.95 | $17.86 |
| 52 Week High | $7.91 | $25.15 |
Technical Indicators
Market Signals| Indicator | UA | INVA |
|---|---|---|
| Relative Strength Index (RSI) | 54.78 | 54.51 |
| Support Level | $4.70 | $20.42 |
| Resistance Level | $4.90 | $21.69 |
| Average True Range (ATR) | 0.18 | 0.48 |
| MACD | 0.03 | 0.04 |
| Stochastic Oscillator | 71.19 | 62.00 |
Price Performance
Historical ComparisonAbout UA Under Armour Inc. Class C
Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and Latin America. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through wholesale partners, company-owned digital channels, and approximately 440 company-owned outlet and full-price stores. The Baltimore-based firm was founded in 1996 and is led by controlling shareholder Kevin Plank.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.